Can your own stem cells reverse frailty? suspended trial holds clues

NCT ID NCT03514537

Terminated Disease control Sponsor: Healeon Medical Inc Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This trial tests whether a person's own stem cells, taken from fat tissue and given back through an IV, can safely improve quality of life and physical function in people with aging frailty. The study plans to enroll 200 adults aged 40 to 90 who have lost energy and exercise tolerance. The trial is currently suspended, so results are not yet available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous stem/stromal cells from fat tissue
What this could lead to: If it works, this could point toward a treatment to improve mobility and energy in frail older adults.
What could go wrong: This is an early, suspended trial with no phase, so results are uncertain. Risks include side effects from the cell infusion procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neurodegenerative disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING DEGENERATIVE DISEASE FRAIL ELDERLY SYNDROME

Contacts and locations

Locations

Fanny Island Campus Medical Building

Colchester, Vermont, 05446, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.